Amarin





















































































If home study is current taking place, can we expect reps in the field finally selling this product end of January? I hope it isn't longer than that since it was FDA approved in July.
 


















Amarin CEO Joe just spoke at JPMorgan Healthcare Conference in San Francisco. He did a great job and anyone lucky enough to get hired by this company has a real opportunity.
 






Definitely a good opportunity. This product is less expensive and has less risks versus the only competitor. If you find it difficult selling this product, I suggest you find a new career. Good luck!
 






This is going to be an easy sell - minimal side effects - purified EPA, works for hypertriglyceridemia, and for mixed dylipidemia. GSK can't make the same claim. The Anchor data will be a key difference to docs.